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Overactive Bladder 
Background 
1. Definition  
o Overactive bladder  
 Syndrome causing urinary urgency and frequency >8 micturitions in 
24 hr 
o It may or may not be associated with incontinence
1
  
2. General info  
o Prevalence is increasing 
o More common in women than men 
o In European population studies  
 Prevalence in >40 yo was 15.6% in men and 17.4% in women  
o 17 million people in United States and 50-100 million people worldwide 
suffer from overactive bladder 
o Most commonly reported symptoms  
 Frequency (85%) 
 Urgency (54%) 
 Urge incontinence (36%) 
o Increased risk of falls, fractures, UTIs, skin infections, sleep disturbances 
and depression
2,4,7
  
o Profound impact on quality of life
1-3
  
 Work 
 Travel 
 Interpersonal activities 
 Physical activities 
 Sexual function 
 Sleep
1,2,4,5,6
  
 
Pathophysiology 
1. Causes  
o Urologic causes  
 Urinary tract infection 
 Obstruction 
 Impaired bladder contractility 
 Calculi / interstitial cystitis 
 Neoplasm
3
  
o Hormonal causes  
 Estrogen deficiency in women 
o Neurologic causes  
 Multiple sclerosis 
 Cervical or lumbar stenosis 
 Disk herniation  
 Spinal cord injury 
o Systemic causes  
 Congestive heart failure 
 Venous insufficiency 
 Diabetes mellitus 
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 Sleep disorders 
o Pharmacologic causes  
 Diuretics, anticholinergics, narcotics, CCBs, antipyschotics, ACEIs, 
NSAIDs
4,7,8,9
  
2. Additional risk factors  
o Age 
o Caffeine 
o Alcohol 
o Obesity 
3. Morbidity  
o UTI / urosepsis 
o Perineal infections 
o Cellulitis 
o Orthostatic hypotension 2° to volume loss 
o Falls / fractures 
4. Mortality  
o Not associated with increased mortality
6-8
  
 
Diagnostics 
1. History / onset and course of symptoms 
2. Past genitourinary disorders  
o BPH 
o UTI 
o Worsening status of other medical conditions  
 DM, CHF, multiple sclerosis, interstitial cystitis 
o Causative medications 
o Degree to which symptoms impact life aids in assessing severity of 
condition 
o Bladder diary  
 Frequency of urination (>8 micturitions) 
 Voiding volumes (<200 mL) 
 Pattern of voiding (urgency with / without incontinence) 
 Lifestyle factors that may contribute to symptoms like caffeine and 
alcohol consumption 
3. Physical exam - findings that may assist evaluation  
o General exam  
 Level of alertness and functional status 
o Vital signs  
 Orthostatic blood pressure and heart rate 
o Cardiovascular  
 Evidence for volume overload 
o Abdominal exam  
 Palpate for masses, tenderness and bladder distension 
o Back exam  
 Point tenderness, evidence of disc herniation and spinal cord injury  
o Extremities  
 Evidence of edema  
o Neurological exam  
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 Evaluation of cognitive status, motor strength, tone, vibration, 
sensations and evidence of peripheral neuropathy 
o Genital exam  
 Women  
 Inspection for vaginal atrophy or inflammation 
 Bimanual exam for masses 
 Rectal exam for masses 
 Men  
 Rectal exam for masses 
 Consistency and symmetry of prostate 
4. Diagnostic testing  
o Laboratory evaluation  
 Clean catch urine specimen for blood, glucose and infection 
 Urine culture if indicated 
 Sterile in and out catheterization can be used to measure post void 
residual urine 
o Imaging  
 Ultrasound to measure post void residual bladder volume 
 Cystoscopy targeted for patients with unexplained hematuria, 
recurrent UTI, or risk factors for cancer 
 Urodynamic testing  
 More complex and invasive and is controversial in 
diagnostic workup of overactive bladder (only indicated if 
primary therapy fails or unclear etiology of overactive 
bladder)
1,2,5
  
 Indicated in older adults with incontinence when the 
underlying etiology remains unclear  
 
Differential Diagnosis 
1. Key differential diagnosis  
o Painful bladder syndrome 
o Stress incontinence 
o Urge incontinence 
o Anxiety 
o Idiopathic urge incontinence 
2. Extensive differential diagnosis  
o Urinary tract infection 
o Cystocele 
o Diabetes mellitus 
o Congestive heart failure 
o Prostatic enlargement, benign or malignant 
o Stroke 
 
Therapeutics 
1. Optimal therapy depends on thorough evaluation followed by treatment of likely 
causes and contributing factors  
o Causes are multifactorial and multimodal therapy includes non-
pharmacologic and pharmacologic agents 
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2. Nonpharmacolgic intervention  
o Pelvic floor muscle exercises (PFME) and pelvic floor electrical stimulation 
(PFES)  
 Effective treatments for urinary incontinence in women  
o Educate about  
 Bladder function 
 Avoidance of caffeine 
 Timing of fluid intake - limited intake in the evening or varied by 
other social activities 
 Managing constipation 
 Pelvic floor muscle exercises 
 Bladder retraining 
 Prompted voiding 
 Habit training 
 Scheduled (timed) voiding 
 Good perineal hygiene 
3. Drug therapy  
o Anticholinergics  
 Highest level of evidence and efficacy 
 No consistent evidence to suggest one more efficacious or better 
tolerated than others  
 Common agents  
 Tolterodine / oxybutynin / propiverine (not available in 
USA)  
o Oxybutynin  
 Good for short term control of social situations 
 Transdermal patch 
 Immediate and extended release  
o Tolterodine 
o Newer agents  
 Trospium  
 Darifenacin 
4. Invasive intervention  
o Electrical stimulation delivered by vaginal or rectal probes may augment 
pelvic muscle contractions and/or modulate detrusor contractions and can 
be helpful in some patients 
o Magnetic stimulation may have similar effects 
o Surgical procedures including motor nerve ablation and augmentation used 
in severe symptoms  
 Surgical repair of incompetent sphincter may be helpful as well
1,6,10
  
 
Follow-Up  
1. Return to office  
o Every 3-6 months 
2. Refer to specialist  
o Persistent symptoms after adequate trial of medical therapy 
o Neurologic conditions 
o Uncertain diagnosis 
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o Tumors 
o Urologic obstruction 
o Need for invasive intervention 
3. Admit to hospital  
o Urosepsis 
o Fever  
o Other symptoms suggesting worsening of urologic status not amenable to 
timely outpatient management 
 
Prognosis 
1. Good with medical and behavioral therapy 
 
Prevention 
1. Screening questionnaire for those with1  
o Recurrent UTI 
o Diabetes 
o Neurologic dz 
o Age >65 years 
2. Avoid caffeine and alcohol 
3. Lose weight if indicated 
4. Manage constipation if indicated 
5. Educational handouts (overactive bladder and incontinence)  
o http://www.patient.co.uk/showdoc/27001041 
o http://familydoctor.org/online/famdocen/home/women/gen-health/189.html  
o http://www.aafp.org/afp/20001201/2447ph.html  
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Evidence-Based Inquiry 
1. What are the indications for urodynamic testing in older adults with incontinence? 
2. What are the most effective nonpharmacologic therapies for urinary incontinence in 
women? 
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